Company
History
Board of Directors
Corporate Management Team
Mission & Vision
Innovation
Brand Promise
Diversity & Inclusion
Therapies
Cardiovascular
Oncology
Critical Care & Infectious Diseases
Rheumatoid Arthritis
Ophthalmology
Neurology
Gynaecology
Anti Diabetics
IV Therapy
Contrast Media
Gastrology
Pain Management
Infrastructure
Manufacturing Facilities
R&D Centre
Global Infrastructure
Partnerships
Partnerships
Events & Exhibitions
Dossier Licensing
Startups
Responsibility
Corporate Social Responsibility (CSR)
Drug Safety & Pharmacovigilance System
Investors
Career
Contact
Investors
Investor Menu
Investors Overview
Board Composition
Terms and Conditions for the appointment of Independent Directors
Board Meeting Notice
Board Meeting Notice - 2024 2025
Board Meeting Notice - 2023 2024
Board Meeting Notice - 2022 2023
Board Meeting Notice - 2021 2022
Board Meeting Notice - 2020-2021
Board Meeting Notice - 2019 2020
Board Meeting Notice - 2018 2019
Board Meeting Notice - 2017 2018
Board Meeting Notice - 2016 2017
Downloads
Share Holding Patterns
Financial Performance
Compliance Reports
Unclaimed Dividends
Corporate Announcement
Related Party Transactions
Transcript & Audio Recordings Of Investor Call
Secretarial Compliance Report
Policies
Outstanding Instruments
Financials Of Subsidiaries
Stock Exchange Intimations
Debt Compliance
Credit Rating - Debentures
Stock Exchange Intimations - FY 2023-24
Stock Exchange Intimations - FY 2022-23
Stock Exchange Intimations - FY 2021-22
Scheme of Amalgamation
Disclosure Under Regulation 30
Postal Ballot
June 21, 2024
Sep 21, 2023
May 28, 2018
EGM 11.12.2020
EGM 16.01.2020
Note on Dividend Tax
Newspaper Publications
Code of Conduct
Corporate Governance
List of Board of Directors
Audit Committee
Nomination & Remuneration Committee
Stakeholder Relationship Committee
Risk Management Committee
Corporate Social Responsibility Committee
Familiarisation Programme for Independent Directors
Contact
Preliminary Placement Document
Placement Document
Scrutinizer Report
AGM
EGM
Postal Ballot
Details of Business
Coming Soon
+91 22 42361110 /
1111
info@archerchem.com
The Company
History
Board of Directors
Corporate Management Team
Mission & Vision
Innovation
Brand Promise
Diversity & Inclusion
Responsibility
Corporate Social Responsibility (CSR)
Drug Safety & Pharmacovigilance System
Infrastructure
Manufacturing Facilities
R&D Centre
Global Infrastructure
Our Therapies
Cardiovascular
Oncology
Critical Care & Infectious Diseases
Rheumatoid Arthritis
Ophthalmology
Neurology
Gynaecology
Anti Diabetics
IV Therapy
Contrast Media
Gastrology
Pain Management
Partnerships
Partnerships
Events & Exhibitions
Dossier Licensing
Startups
Legal Policy
Terms of Use
Privacy Policy
Careers
Contact Us
